James Trager

2.7k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

James Trager is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, James Trager has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 29 papers in Immunology and 9 papers in Molecular Biology. Recurrent topics in James Trager's work include CAR-T cell therapy research (26 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (14 papers). James Trager is often cited by papers focused on CAR-T cell therapy research (26 papers), Immune Cell Function and Interaction (16 papers) and Cancer Immunotherapy and Biomarkers (14 papers). James Trager collaborates with scholars based in United States, Germany and Australia. James Trager's co-authors include Woodring E. Wright, Shawn E. Holt, Gregg B. Morin, Nadeem A. Sheikh, Andrea Bodnár, Libin Ma, Jerry W. Shay, Scott L. Weinrich, William H. Andrews and Nam W. Kim and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

James Trager

48 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT

1997 812 citations Scott L. Weinrich, R. Pruzan et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Trager United States	16	1.1k	980	640	622	253	50	2.2k
Raquel Blanco Spain	15	1.4k 1.2×	354 0.4×	322 0.5×	403 0.6×	86 0.3×	18	1.9k
Joan M. Robbins United States	21	1.3k 1.2×	571 0.6×	716 1.1×	442 0.7×	113 0.4×	49	2.6k
John Maciejowski United States	21	1.9k 1.8×	366 0.4×	328 0.5×	350 0.6×	105 0.4×	37	2.5k
Jasper Mullenders Netherlands	17	2.0k 1.8×	130 0.1×	192 0.3×	651 1.0×	204 0.8×	25	2.7k
Guillermo E. Taccioli United States	26	3.9k 3.6×	445 0.5×	972 1.5×	1.2k 2.0×	120 0.5×	39	4.9k
Zhong Deng United States	29	1.7k 1.6×	981 1.0×	184 0.3×	665 1.1×	38 0.2×	44	2.6k
H E Varmus United States	14	1.2k 1.1×	729 0.7×	184 0.3×	231 0.4×	32 0.1×	22	1.8k
Takaaki Sato Japan	18	1.6k 1.4×	151 0.2×	350 0.5×	802 1.3×	158 0.6×	34	2.6k
Peter Ping Lin United States	32	802 0.7×	275 0.3×	608 0.9×	950 1.5×	319 1.3×	69	2.5k
Novalia Pishesha United States	19	803 0.7×	225 0.2×	699 1.1×	567 0.9×	94 0.4×	32	1.8k

Countries citing papers authored by James Trager

Since Specialization

Citations

This map shows the geographic impact of James Trager's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Trager with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Trager more than expected).

Fields of papers citing papers by James Trager

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Trager. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Trager. The network helps show where James Trager may publish in the future.

Co-authorship network of co-authors of James Trager

This figure shows the co-authorship network connecting the top 25 collaborators of James Trager. A scholar is included among the top collaborators of James Trager based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Trager. James Trager is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hansen, Kyle, et al.. (2023). Abstract 3183: Combination of anti-EGFR antibody cetuximab with NKX101, an allogeneic NKG2D-L targeting NK cell therapy, enhances potency and in vitro cytotoxicity against solid tumors. Cancer Research. 83(7_Supplement). 3183–3183. 1 indexed citations

Li, Bing, Nitin Patel, Daniel Bedinger, et al.. (2023). Abstract A044: Screening and characterization of CD38 chimeric antigen receptors for the development of natural killer cell-based therapies. Cancer Immunology Research. 11(12_Supplement). A044–A044. 1 indexed citations

Dickinson, Michael, Nada Hamad, Christian Bryant, et al.. (2023). S261: FIRST IN HUMAN DATA OF NKX019, AN ALLOGENEIC CAR NK FOR THE TREATMENT OF RELAPSED/REFRACTORY (R/R) B-CELL MALIGNANCIES. HemaSphere. 7(S3). e37234fb–e37234fb. 7 indexed citations

Tohmé, Mira, Tina Davis, Hadia Lemar, et al.. (2022). 902 NKX019, an off-the-shelf CD19 CAR-NK cell, mediates improved anti-tumor activity and persistence in combination with CD20-directed therapeutic mAbs. Regular and Young Investigator Award Abstracts. A940–A940. 3 indexed citations

Guo, Chao, et al.. (2021). 113 CISH gene-knockout anti-CD70-CAR NK cells demonstrate potent anti-tumor activity against solid tumor cell lines and provide partial resistance to tumor microenvironment inhibition. SHILAP Revista de lepidopterología. A123–A123. 4 indexed citations

Lemar, Hadia, et al.. (2021). 128 KIR haplotype can inform donor selection production of allogeneic memory-like CAR NK cells for clinical application. SHILAP Revista de lepidopterología. A137–A137. 1 indexed citations

Zhang, Li, Jason Cham, Alan Paciorek, et al.. (2017). 3D: diversity, dynamics, differential testing – a proposed pipeline for analysis of next-generation sequencing T cell repertoire data. BMC Bioinformatics. 18(1). 129–129. 22 indexed citations

Sheikh, Nadeem A., Jason Cham, Li Zhang, et al.. (2016). Clonotypic Diversification of Intratumoral T Cells Following Sipuleucel-T Treatment in Prostate Cancer Subjects. Cancer Research. 76(13). 3711–3718. 50 indexed citations

Gulley, James L., Ravi A. Madan, Russell K. Pachynski, et al.. (2016). Role of Antigen Spread and Distinctive Characteristics of Immunotherapy in Cancer Treatment. JNCI Journal of the National Cancer Institute. 109(4). 156 indexed citations

10.

GuhaThakurta, Debraj, Nadeem A. Sheikh, Li-Qun Fan, et al.. (2015). Humoral Immune Response against Nontargeted Tumor Antigens after Treatment with Sipuleucel-T and Its Association with Improved Clinical Outcome. Clinical Cancer Research. 21(16). 3619–3630. 101 indexed citations

11.

GuhaThakurta, Debraj, et al.. (2013). Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome. Expert Review of Clinical Pharmacology. 6(4). 387–401. 14 indexed citations

12.

Sheikh, Nadeem A., Daniel P. Petrylak, Philip W. Kantoff, et al.. (2012). Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer. Cancer Immunology Immunotherapy. 62(1). 137–147. 203 indexed citations

13.

Sheikh, Nadeem A., Eric J. Small, David I. Quinn, et al.. (2012). Sipuleucel-T product characterization across different disease states of prostate cancer.. Journal of Clinical Oncology. 30(5_suppl). 42–42. 9 indexed citations

14.

Wesley, Johnna D., James B. Whitmore, James Trager, & Nadeem A. Sheikh. (2012). An overview of sipuleucel-T: Autologous cellular immunotherapy for prostate cancer. Human Vaccines & Immunotherapeutics. 8(4). 520–527. 24 indexed citations

15.

Trager, James, Scott L. Weinrich, Akira Asai, et al.. (2002). Reconstitution of telomerase activity utilizing human catalytic subunit expressed in insect cells. Biochemical and Biophysical Research Communications. 298(1). 144–150. 4 indexed citations

16.

Weinrich, Scott L., R. Pruzan, Libin Ma, et al.. (1997). Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nature Genetics. 17(4). 498–502. 812 indexed citations breakdown →

17.

Trager, James & Greg S. Martin. (1997). The role of the Src homology-2 domain in the lethal effect of Src expression in the yeast saccharomyces cerevisiae. The International Journal of Biochemistry & Cell Biology. 29(4). 635–648. 6 indexed citations

18.

Plötz, W, et al.. (1995). [Vertebral replacement in palliative tumor therapy. Possible surgical procedures--significant improvement in quality of life].. PubMed. 113(31). 437–40. 1 indexed citations

19.

Florio, Monica, Linda K. Wilson, James Trager, Jeremy Thorner, & Greg S. Martin. (1994). Aberrant protein phosphorylation at tyrosine is responsible for the growth-inhibitory action of pp60v-src expressed in the yeast Saccharomyces cerevisiae.. Molecular Biology of the Cell. 5(3). 283–296. 29 indexed citations

20.

Trager, James, et al.. (1985). Mössbauer and Perturbed Angular Correlation Studies of the Distribution and Diffusion of Hydrogen Near Impurities in Metal Hydrogen Systems*. Zeitschrift für Physikalische Chemie. 145(1-2). 129–140. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact